Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Solvay    SOLB   BE0003470755

SOLVAY (SOLB)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
06/19/2018 06/20/2018 06/21/2018 06/22/2018 06/25/2018 Date
111.25(c) 111.75(c) 109.9(c) 110.8(c) 110.05 Last
382 590 240 055 293 541 204 502 6 634 Volume
-0.85% +0.45% -1.66% +0.82% -0.68% Change
More quotes
Financials (EUR)
Sales 2018 10 312 M
EBIT 2018 1 481 M
Net income 2018 701 M
Debt 2018 2 817 M
Yield 2018 3,28%
Sales 2019 10 788 M
EBIT 2019 1 652 M
Net income 2019 781 M
Debt 2019 2 845 M
Yield 2019 3,38%
P/E ratio 2018 16,87
P/E ratio 2019 14,31
EV / Sales2018 1,41x
EV / Sales2019 1,35x
Capitalization 11 731 M
More Financials
Company
Solvay SA engages in the manufacture and distribution of chemical and plastic products.It operates through the following business segments: Advanced Formulations, Advanced Materials, Performance Chemicals, Functional Polymers, and Corporate and Business Services.The Advanced Formulations segment... 
Sector
Commodity Chemicals
Calendar
08/01Earnings Release
More about the company
Surperformance© ratings of Solvay
Trading Rating : Investor Rating :
More Ratings
Latest news on SOLVAY
06/18SOLVAY : and EPFL team up on an atomic-scale modeling project
AQ
06/15SOLVAY : 's high-stiffness Ixef PARA enables Reign Medical to develop a more rob..
AQ
06/14SOLVAY : unveils the transformation project of its Brussels headquarters and amb..
AQ
06/14SOLVAY : SHL Architects reveals images for Solvay's new HQ
AQ
06/13SOLVAY : 's High-Stiffness Ixef PARA Enables Reign Medical to Develop a More Rob..
AQ
06/13SOLVAY : and EPFL team up on an atomic-scale modeling project
PU
06/12SOLVAY : high-stiffness Ixef® PARA enables Reign Medical to develop a more robus..
PU
06/12SOLVAY : Argosy signs agreement with Solvay to transition the Composite Material..
AQ
06/11SOLVAY : unveils the transformation project of its Brussels headquarters and amb..
PU
06/08SOLVAY : Argosy Signs Agreement With Solvay to Transition the Composite Material..
AQ
More news
Sector news : Commodity Chemicals - NEC
06/21Linde, Praxair offer concessions in bid to win EU okay for merger
RE
06/20ELON MUSK : Tesla's Musk says Germany a front runner for Europe Gigafactory
RE
06/20Tesla's Musk says Germany a front runner for Europe Gigafactory
RE
06/20EXCLUSIVE : Taiyo Nippon, Carlyle frontrunners to buy Linde and Praxair assets -..
RE
06/19Want to Invest in Lithium and Cobalt? Good Prices Are Hard to Find -- Update
DJ
More sector news : Commodity Chemicals - NEC
4-Traders Strategies on SOLVAY 
SOLVAY - 2017
The calm spell can be taken advantage of to put on new positions
BUY
SOLVAY - 2017
No turn-around in sight
BUY
More Strategies
Latest Tweets
06/21« sees the momentum coming from all industries. The more we meet customers, .. 
06/17.: We got in contact with Solvay?s and convinced them of the many touchpoints.. 
06/15Einstein, Curie, Bohr, Planck, Heisenberg, Schrödinger… was this the greatest..
827
06/13Let's put ourselves in customer's shoes! Solvay Peroxides convention invites ..
5
06/13Solvay : and EPFL team up on an atomic-scale modeling project  
More tweets
Qtime:51
News from SeekingAlpha
06/03THE NEST EGG PORTFOLIO : Glencore - The Commodity Giant Is Now Really Back 
05/23SOLVAY : A Strong And Reliable Chemical Powerhouse 
05/04Solvay's (SVYSF) CEO Jean-Pierre Clamadieu on Q1 2018 Results - Earnings Call.. 
05/03Solvay S.A. reports Q1 results 
03/22BASF : A German Powerhouse Worth Buying 
Chart SOLVAY
Duration : Period :
Solvay Technical Analysis Chart | SOLB | BE0003470755 | 4-Traders
Technical analysis trends SOLVAY
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 130 €
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
Jean-Pierre Clamadieu Chief Executive Officer & Director
Nicolas Jacques Boël Chairman
Karim Hajjar Chief Financial Officer
Jean-Marie Ernest Solvay Non-Independent Director
Bernhard Scheuble Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SOLVAY-5.18%13 671
SAUDI BASIC INDUSTRIES CORPORATION SJSC--.--%100 800
AIR LIQUIDE3.62%53 670
PRAXAIR0.77%45 445
LYONDELLBASELL INDUSTRIES0.63%43 528
SHIN-ETSU CHEMICAL CO LTD-16.18%38 799